Expiring federal contract
75D30123C17978 — Mckesson Specialty Distribution LLC
Department of Health and Human Services · Centers for Disease Control and Prevention
- Contract / PIID
- 75D30123C17978
- Incumbent
- Mckesson Specialty Distribution LLC
- Incumbent UEI
- GY7SZLBCL9Y1
- Current end date
- January 31, 2027
- Potential total value
- $203,925,445
- Obligated
- $203,925,445
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- R604 — SUPPORT- ADMINISTRATIVE: MAILING/DISTRIBUTION
- Set-aside
- Full & Open
- Start date
- February 1, 2024
- Place of performance
- TN
- Award type
- DEFINITIVE CONTRACT
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
CENTRALIZED VACCINE DISTRIBUTION
Likely rebid window (estimate)
- Sources Sought / RFI: about Jan 2026 – Jul 2026 (6–12 months before the end date)
- RFP: about Sep 2026 – Nov 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325412)
- 75H71226F80004 — Mckesson Corporation · ends November 25, 2026 · $114K
- 75H71224P00137 — Four Points Technology, L.L.C. · ends November 30, 2026 · $240K
- 75H71226F80005 — Mckesson Corporation · ends December 21, 2026 · $1.6M
- 75H71026P00562 — Mckesson Corporation · ends December 31, 2026 · $131K
- 75N92026P00029 — Medunik USA INC · ends December 31, 2026 · $210K
- 75N93024P01131 — United Biopharma, INC. · ends December 31, 2026 · $400K
- 75A50120C00092 — Phlow Corp. · ends January 13, 2027 · $697M
- 75N95019F00088 — Mriglobal · ends January 31, 2027 · $2.4M
- 75N90024F00080 — Ino Therapeutics LLC · ends February 28, 2027 · $115K
- 75H71126F80051 — Sanofi Vaccines US INC. · ends March 14, 2027 · $2.0M